Economic evaluation of desirudin vs heparin in deep vein thrombosis prevention after hip replacement surgery

PharmacoEconomics

Volumn 13, Issue 1 PART II, 1998, Pages 111-118

  Levin, Lars Ake ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DESULFATOHIRUDIN; HEPARIN;

ARTICLE; COST EFFECTIVENESS ANALYSIS; DEEP VEIN THROMBOSIS; DRUG COST; ECONOMIC EVALUATION; MODEL; PRIORITY JOURNAL; TOTAL HIP PROSTHESIS;

ANTICOAGULANTS; ARTHROPLASTY, REPLACEMENT, HIP; CLINICAL TRIALS; COST-BENEFIT ANALYSIS; HEPARIN; HIRUDIN THERAPY; HIRUDINS; HUMANS; MODELS, ECONOMIC; RECOMBINANT PROTEINS; SWEDEN; THROMBOSIS;

EID: 0031973368     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-199813010-00010     Document Type: Article

References (1)

1. Oster G, Tudcn RL, Colditz GA, Prevention of venous thrombosis after general surgery: cost-effectiveness analysis of alternative approaches to prophylaxis. Am J Med 1987; 82: 889-99